{"transactions":[{"id":4626511,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Share Option (Right to Buy)","published_at":"2026-09-25T00:21:53.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":25.64,"expiration_date":"2028-07-31","underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001898490-26-000017","document":"form4-09252026_120949.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000017/form4-09252026_120949.xml","form_type":"4"}},{"id":4626510,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-09-25T00:21:53.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":89062,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, pursuant to the Merger Agreement, each award of restricted stock units of the Issuer (a \"Company RSU Award\") that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the Per Share Cash Consideration multiplied by (ii) the number of Ordinary Shares underlying such Company RSU Award (subject to any required tax withholdings as provided in the Merger Agreement) plus (iii) one CVR for each Ordinary Share underlying such Company RSU Award."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001898490-26-000017","document":"form4-09252026_120949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000017/form4-09252026_120949.xml","form_type":"4"}},{"id":4626509,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-09-25T00:21:53.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":124414,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 23, 2026, pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated June 28, 2026, by and among the Issuer, Zymeworks Inc. (\"Parent\"), and Zymeworks Merger Sub 1, a wholly owned subsidiary of Parent, the Issuer became a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), pursuant to the Merger Agreement, each ordinary share, par value $0.00001 per share, of the Issuer (\"Ordinary Share\") held by the reporting person as of immediately prior to the Effective Time was cancelled and converted into the right to receive (i) $17.00 in cash, without interest (the \"Per Share Cash Consideration\") and (ii) one contingent value right (a \"CVR\"). Each CVR represents a non-tradeable contractual contingent right to receive cash payments based on the achievement of certain commercial milestones following the Effective Time."}],"balance_after":89062,"source":{"system":"sec-edgar","filing":"0001898490-26-000017","document":"form4-09252026_120949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000017/form4-09252026_120949.xml","form_type":"4"}},{"id":4621859,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-09-17T21:52:04.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":6657,"price":17.0342,"value":113396.6694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $17.02 to $17.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":213476,"source":{"system":"sec-edgar","filing":"0001898490-26-000014","document":"form4-09172026_090959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000014/form4-09172026_090959.xml","form_type":"4"}},{"id":4621858,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-09-17T21:52:04.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":3328,"price":17.0343,"value":56690.1504,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $17.02 to $17.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":220133,"source":{"system":"sec-edgar","filing":"0001898490-26-000014","document":"form4-09172026_090959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000014/form4-09172026_090959.xml","form_type":"4"}},{"id":4621857,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-09-17T21:52:04.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":3329,"price":17.0341,"value":56706.5189,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $17.02 to $17.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":223461,"source":{"system":"sec-edgar","filing":"0001898490-26-000014","document":"form4-09172026_090959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000014/form4-09172026_090959.xml","form_type":"4"}},{"id":677586,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-08-24T22:00:15.000Z","date":"2026-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":5667,"price":16.95,"value":96055.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":226790,"source":{"system":"sec-edgar","filing":"0001898490-26-000012","document":"form4-08242026_100811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000012/form4-08242026_100811.xml","form_type":"4"}},{"id":734416,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-06-17T23:56:36.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":6657,"price":16.3856,"value":109078.9392,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $16.21 to $16.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":232457,"source":{"system":"sec-edgar","filing":"0001898490-26-000010","document":"form4-06172026_110631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000010/form4-06172026_110631.xml","form_type":"4"}},{"id":734415,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-06-17T23:56:36.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":3328,"price":16.3838,"value":54525.2864,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $16.21 to $16.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":239114,"source":{"system":"sec-edgar","filing":"0001898490-26-000010","document":"form4-06172026_110631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000010/form4-06172026_110631.xml","form_type":"4"}},{"id":734414,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-06-17T23:56:36.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":3329,"price":16.3902,"value":54562.9758,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $16.21 to $16.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":242442,"source":{"system":"sec-edgar","filing":"0001898490-26-000010","document":"form4-06172026_110631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000010/form4-06172026_110631.xml","form_type":"4"}},{"id":766254,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-05-22T22:18:00.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":5678,"price":16.55,"value":93970.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":245771,"source":{"system":"sec-edgar","filing":"0001898490-26-000008","document":"form4-05222026_100557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000008/form4-05222026_100557.xml","form_type":"4"}},{"id":816909,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-04-03T22:03:59.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":251449,"source":{"system":"sec-edgar","filing":"0001898490-26-000006","document":"form4-04032026_100454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000006/form4-04032026_100454.xml","form_type":"4"}},{"id":835233,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-03-18T22:12:31.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":7766,"price":13.9162,"value":108073.2092,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $13.755 to $14.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":232699,"source":{"system":"sec-edgar","filing":"0001898490-26-000004","document":"form4-03182026_100327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000004/form4-03182026_100327.xml","form_type":"4"}},{"id":835232,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-03-18T22:12:31.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":15534,"price":14,"value":217476.0,"ownership":{"direct":true},"balance_after":240465,"source":{"system":"sec-edgar","filing":"0001898490-26-000004","document":"form4-03182026_100327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000004/form4-03182026_100327.xml","form_type":"4"}},{"id":835231,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-03-18T22:12:31.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":7767,"price":13.9163,"value":108087.9021,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $13.755 to $14.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":255999,"source":{"system":"sec-edgar","filing":"0001898490-26-000004","document":"form4-03182026_100327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000004/form4-03182026_100327.xml","form_type":"4"}},{"id":885291,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2026-02-25T00:35:12.000Z","date":"2026-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":13929,"price":19.66,"value":273844.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":263766,"source":{"system":"sec-edgar","filing":"0001898490-26-000002","document":"form4-02252026_120208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849026000002/form4-02252026_120208.xml","form_type":"4"}},{"id":979182,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-12-05T23:02:25.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":15534,"price":18.7493,"value":291251.6262,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $18.52 to $18.94 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":277695,"source":{"system":"sec-edgar","filing":"0001898490-25-000008","document":"form4-12052025_111222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849025000008/form4-12052025_111222.xml","form_type":"4"}},{"id":979181,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-12-05T23:02:25.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":7766,"price":18.7508,"value":145618.7128,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $18.52 to $18.94 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":293229,"source":{"system":"sec-edgar","filing":"0001898490-25-000008","document":"form4-12052025_111222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849025000008/form4-12052025_111222.xml","form_type":"4"}},{"id":979180,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-12-05T23:02:25.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":7767,"price":18.7499,"value":145630.4733,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $18.52 to $18.94 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":300995,"source":{"system":"sec-edgar","filing":"0001898490-25-000008","document":"form4-12052025_111222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849025000008/form4-12052025_111222.xml","form_type":"4"}},{"id":990316,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-11-24T23:11:13.000Z","date":"2025-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":9060,"price":17.9,"value":162174.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":308762,"source":{"system":"sec-edgar","filing":"0001898490-25-000006","document":"form4-11242025_111109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000189849025000006/form4-11242025_111109.xml","form_type":"4"}},{"id":1058382,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-08-22T22:01:59.000Z","date":"2025-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":9096,"price":13.39,"value":121795.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":317822,"source":{"system":"sec-edgar","filing":"0001415889-25-022794","document":"form4-08222025_100855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588925022794/form4-08222025_100855.xml","form_type":"4"}},{"id":1086690,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-07-16T22:01:13.000Z","date":"2025-07-14","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":11.3879,"value":45551.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices from $11.24 to $11.46 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":326918,"source":{"system":"sec-edgar","filing":"0001415889-25-019869","document":"form4-07162025_100710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588925019869/form4-07162025_100710.xml","form_type":"4"}},{"id":1086689,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-07-16T22:01:13.000Z","date":"2025-07-14","kind":"sale","planned":true,"acquired":false,"shares":5318,"price":11.3855,"value":60548.089,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices from $11.24 to $11.46 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":330918,"source":{"system":"sec-edgar","filing":"0001415889-25-019869","document":"form4-07162025_100710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588925019869/form4-07162025_100710.xml","form_type":"4"}},{"id":1086688,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-07-16T22:01:13.000Z","date":"2025-07-14","kind":"sale","planned":true,"acquired":false,"shares":682,"price":11.3927,"value":7769.8214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $11.24 to $11.465 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":336236,"source":{"system":"sec-edgar","filing":"0001415889-25-019869","document":"form4-07162025_100710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588925019869/form4-07162025_100710.xml","form_type":"4"}},{"id":1123170,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-06-04T22:04:21.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":24000,"price":11,"value":264000.0,"ownership":{"direct":true},"balance_after":336918,"source":{"system":"sec-edgar","filing":"0001415889-25-015642","document":"form4-06042025_100617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588925015642/form4-06042025_100617.xml","form_type":"4"}},{"id":1137503,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-05-22T22:39:25.000Z","date":"2025-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":9120,"price":9.45,"value":86184.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":360918,"source":{"system":"sec-edgar","filing":"0001415889-25-014257","document":"form4-05222025_100521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588925014257/form4-05222025_100521.xml","form_type":"4"}},{"id":1167177,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-04-23T22:00:35.000Z","date":"2025-04-21","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":9,"value":36000.0,"ownership":{"direct":true},"balance_after":370038,"source":{"system":"sec-edgar","filing":"0001415889-25-011227","document":"form4-04232025_100431.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588925011227/form4-04232025_100431.xml","form_type":"4"}},{"id":1229604,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-03-04T23:05:02.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":374038,"source":{"system":"sec-edgar","filing":"0001415889-25-006668","document":"form4-03042025_110355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588925006668/form4-03042025_110355.xml","form_type":"4"}},{"id":1249931,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-02-25T00:24:52.000Z","date":"2025-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":15810,"price":9.66,"value":152724.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":299038,"source":{"system":"sec-edgar","filing":"0001415889-25-005347","document":"form4-02252025_120248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588925005347/form4-02252025_120248.xml","form_type":"4"}},{"id":1249930,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-02-25T00:24:52.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":5283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 2, 2024 the reporting person was granted a performance restricted stock unit award that vests based on the achievement of certain performance conditions and continued employment. On February 10, 2025, the performance conditions were deemed achieved as to 5,283 RSUs, and such RSUs became eligible to vest based on the reporting person's continued service."}],"balance_after":314848,"source":{"system":"sec-edgar","filing":"0001415889-25-005347","document":"form4-02252025_120248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588925005347/form4-02252025_120248.xml","form_type":"4"}},{"id":1296553,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2025-01-23T23:05:32.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":9,"value":36000.0,"ownership":{"direct":true},"balance_after":309565,"source":{"system":"sec-edgar","filing":"0001415889-25-001957","document":"form4-01232025_110129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588925001957/form4-01232025_110129.xml","form_type":"4"}},{"id":1354657,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2024-11-22T23:04:47.000Z","date":"2024-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":9178,"price":9.97,"value":91504.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":313565,"source":{"system":"sec-edgar","filing":"0001415889-24-027564","document":"form4-11222024_111143.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588924027564/form4-11222024_111143.xml","form_type":"4"}},{"id":1366836,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2024-11-14T01:42:07.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":9,"value":36000.0,"ownership":{"direct":true},"balance_after":322743,"source":{"system":"sec-edgar","filing":"0001415889-24-026766","document":"form4-11142024_011103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588924026766/form4-11142024_011103.xml","form_type":"4"}},{"id":1425641,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2024-08-23T00:03:38.000Z","date":"2024-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":9222,"price":8.22,"value":75804.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":326743,"source":{"system":"sec-edgar","filing":"0001415889-24-022084","document":"form4-08232024_120835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588924022084/form4-08232024_120835.xml","form_type":"4"}},{"id":1455425,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2024-07-12T22:15:14.000Z","date":"2024-07-10","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":9,"value":36000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/14/2024."}],"balance_after":335965,"source":{"system":"sec-edgar","filing":"0001415889-24-019534","document":"form4-07122024_100709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588924019534/form4-07122024_100709.xml","form_type":"4"}},{"id":1505753,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2024-05-22T22:02:53.000Z","date":"2024-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":9268,"price":9.1,"value":84338.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":339965,"source":{"system":"sec-edgar","filing":"0001415889-24-014133","document":"form4-05222024_100547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588924014133/form4-05222024_100547.xml","form_type":"4"}},{"id":1547955,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2024-04-04T22:09:23.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":349233,"source":{"system":"sec-edgar","filing":"0001415889-24-010320","document":"form4-04042024_100416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588924010320/form4-04042024_100416.xml","form_type":"4"}},{"id":1625732,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2024-02-23T01:04:32.000Z","date":"2024-02-22","kind":"sale","planned":true,"acquired":false,"shares":1254,"price":8.71,"value":10922.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023."}],"balance_after":311733,"source":{"system":"sec-edgar","filing":"0001415889-24-004958","document":"form4-02232024_010211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588924004958/form4-02232024_010211.xml","form_type":"4"}},{"id":1625731,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2024-02-23T01:04:32.000Z","date":"2024-02-20","kind":"tax_withholding","planned":true,"acquired":false,"shares":18219,"price":8.92,"value":162513.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":312987,"source":{"system":"sec-edgar","filing":"0001415889-24-004958","document":"form4-02232024_010211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588924004958/form4-02232024_010211.xml","form_type":"4"}},{"id":1731509,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2023-11-22T23:07:37.000Z","date":"2023-11-21","kind":"sale","planned":true,"acquired":false,"shares":1378,"price":10.29,"value":14179.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023."}],"balance_after":331206,"source":{"system":"sec-edgar","filing":"0001415889-23-015446","document":"form4-11222023_111131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588923015446/form4-11222023_111131.xml","form_type":"4"}},{"id":1731508,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2023-11-22T23:07:37.000Z","date":"2023-11-20","kind":"tax_withholding","planned":true,"acquired":false,"shares":7982,"price":10.37,"value":82773.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":332584,"source":{"system":"sec-edgar","filing":"0001415889-23-015446","document":"form4-11222023_111131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588923015446/form4-11222023_111131.xml","form_type":"4"}},{"id":1797902,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2023-08-24T22:05:07.000Z","date":"2023-08-22","kind":"sale","planned":true,"acquired":false,"shares":1807,"price":9.47,"value":17112.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023."}],"balance_after":340566,"source":{"system":"sec-edgar","filing":"0001415889-23-012621","document":"form4-08242023_100801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588923012621/form4-08242023_100801.xml","form_type":"4"}},{"id":1799860,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2023-08-22T22:10:22.000Z","date":"2023-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":10460,"price":9.7,"value":101462.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":342373,"source":{"system":"sec-edgar","filing":"0001415889-23-012510","document":"form4-08222023_100816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588923012510/form4-08222023_100816.xml","form_type":"4"}},{"id":1859155,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2023-06-12T22:08:11.000Z","date":"2023-06-08","kind":"sale","planned":false,"acquired":false,"shares":1790,"price":11.13,"value":19922.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023."}],"balance_after":352833,"source":{"system":"sec-edgar","filing":"0001415889-23-009636","document":"form4-06122023_100608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588923009636/form4-06122023_100608.xml","form_type":"4"}},{"id":1881354,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2023-05-23T23:40:08.000Z","date":"2023-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":5567,"price":11.21,"value":62406.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":354623,"source":{"system":"sec-edgar","filing":"0001415889-23-008668","document":"form4-05232023_110503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588923008668/form4-05232023_110503.xml","form_type":"4"}},{"id":1957039,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2023-03-13T21:57:18.000Z","date":"2023-03-09","kind":"sale","acquired":false,"shares":4000,"price":10.2,"value":40800.0,"ownership":{"direct":true},"balance_after":360190,"source":{"system":"sec-edgar","filing":"0001415889-23-004799","document":"form4-03132023_090313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588923004799/form4-03132023_090313.xml","form_type":"4"}},{"id":1974799,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2023-03-04T01:29:54.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":364190,"source":{"system":"sec-edgar","filing":"0001415889-23-004269","document":"form4-03042023_010344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588923004269/form4-03042023_010344.xml","form_type":"4"}},{"id":2000325,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2023-02-23T00:18:38.000Z","date":"2023-02-20","kind":"tax_withholding","acquired":false,"shares":7119,"price":10.44,"value":74322.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":289190,"source":{"system":"sec-edgar","filing":"0001415889-23-003061","document":"form4-02232023_120227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588923003061/form4-02232023_120227.xml","form_type":"4"}},{"id":2107227,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2022-11-22T21:02:20.000Z","date":"2022-11-20","kind":"tax_withholding","acquired":false,"shares":23268,"price":10.85,"value":252457.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":296309,"source":{"system":"sec-edgar","filing":"0001415889-22-011667","document":"form4-11222022_091107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588922011667/form4-11222022_091107.xml","form_type":"4"}},{"id":2176281,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2022-08-23T22:54:30.000Z","date":"2022-08-19","kind":"tax_withholding","acquired":false,"shares":10413,"price":9.34,"value":97257.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":319577,"source":{"system":"sec-edgar","filing":"0001415889-22-008979","document":"form4-08232022_030819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588922008979/form4-08232022_030819.xml","form_type":"4"}},{"id":2258629,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2022-05-24T23:11:35.000Z","date":"2022-05-23","kind":"sale","acquired":false,"shares":1081,"price":8.93,"value":9653.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 5/17/21."}],"balance_after":329990,"source":{"system":"sec-edgar","filing":"0001415889-22-005627","document":"form4-05242022_040525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588922005627/form4-05242022_040525.xml","form_type":"4"}},{"id":2258628,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2022-05-24T23:11:35.000Z","date":"2022-05-20","kind":"tax_withholding","acquired":false,"shares":2200,"price":8.74,"value":19228.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":331071,"source":{"system":"sec-edgar","filing":"0001415889-22-005627","document":"form4-05242022_040525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588922005627/form4-05242022_040525.xml","form_type":"4"}},{"id":2361397,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2022-03-03T00:08:19.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":2356,"price":10.1641,"value":23946.6196,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 5/17/21."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices from $10.02 to $10.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":333271,"source":{"system":"sec-edgar","filing":"0001415889-22-002174","document":"form4-03022022_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588922002174/form4-03022022_040301.xml","form_type":"4"}},{"id":2379092,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COMM & MEDICAL AFFAIRS"}}],"security":"Ordinary Shares","published_at":"2022-02-23T23:22:10.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":11824,"price":9.61,"value":113628.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":335627,"source":{"system":"sec-edgar","filing":"0001415889-22-001695","document":"form4-02232022_030255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000141588922001695/form4-02232022_030255.xml","form_type":"4"}},{"id":2470213,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":20424,"kind":"person","name":"Farnum Rhonda","position":1,"cik":"0001898490","reported_name":"Farnum Rhonda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Comm & Medical Affairs"}}],"security":"Ordinary Shares","published_at":"2021-12-17T00:00:07.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":347451,"source":{"system":"sec-edgar","filing":"0001179110-21-011076","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898490/000117911021011076/edgar.xml","form_type":"4"}}]}